Evaluation of Diet and Symptom Severity in Disorder of Gut–Brain Interaction
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Design
2.2. Research Tools
2.3. Study Group
2.4. Statistical Analysis
3. Results
3.1. Analysis of Perceived Gastrointestinal Complaints
3.2. Analysis of the Frequency of Consumption of Individual Food Groups
4. Discussion
Strengths and Weaknesses of the Study
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Black, C.J.; Drossman, D.A.; Talley, N.J.; Ruddy, J.; Ford, A.C. Functional gastrointestinal disorders: Advances in understanding and management. Lancet 2020, 396, 1664–1674. [Google Scholar] [CrossRef] [PubMed]
- Settembre, C.; D’Antonio, E.; Moscato, P.; Loi, G.; Santonicola, A.; Iovino, P. Association among Disorders of Gut-Brain Interaction (DGBI) and Fibromyalgia: A Prospective Study. J. Clin. Med. 2022, 11, 809. [Google Scholar] [CrossRef]
- Toca, M.C.; Balbarrey, S.; Bastianelli, C.; Guzmán, L.; Leta, K. Functional gastrointestinal disorders. How to manage them without medication. Arch. Argent Pediatr. 2022, 120, 346–353. [Google Scholar] [CrossRef] [PubMed]
- Benninga, M.A.; Nurko, S.; Faure, C.; Hyman, P.E.; Roberts, I.S.J.; Schechter, N.L. Childhood functional gastrointestinal disorders: Neonate/toddler. Gastroenterology 2016, 150, 1443–1455. [Google Scholar] [CrossRef] [PubMed]
- Sperber, A.D.; Bangdiwala, S.I.; Drossman, D.A.; Ghoshal, U.C.; Simren, M.; Tack, J.; Whitehead, W.E.; Dumitrascu, D.L.; Fang, X.; Fukudo, S.; et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology 2021, 160, 99–114. [Google Scholar] [CrossRef] [PubMed]
- Duffy, M.; Boggiano, V.L.; Ganesh, R.; Mueller, M. Functional Gastrointestinal Disorders. Prim. Care 2023, 50, 429–446. [Google Scholar] [CrossRef] [PubMed]
- Holtmann, G.; Shah, A.; Morrison, M. Pathophysiology of Functional Gastrointestinal Disorders: A Holistic Overview. Dig. Dis. 2017, 35, 5–13. [Google Scholar] [CrossRef] [PubMed]
- Drossman, D.A. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology 2016, 150, 1262–1279. [Google Scholar] [CrossRef]
- Wallner, G.; Dziki, A.; Dąbrowski, A. Zaburzenia Czynnościowe Układu Pokarmowego; Czelej: Lublin, Poland, 2018. [Google Scholar]
- Mulak, S.A.; Smereka, A.; Paradowski, L. Nowości i modyfikacje w Kryteriach Rzymskich IV. Gastroenterol. Klin. 2016, 8, 52–61. [Google Scholar]
- Mayer, E.A. Gut feelings: The emerging biology of gut-brain communication. Nat. Rev. Neurosci. 2011, 12, 453–466. [Google Scholar] [CrossRef]
- Frazier, T.H.; DiBaise, J.K.; McClain, C.J. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J. Parenter. Enteral Nutr. 2011, 35, 14S–20S. [Google Scholar] [CrossRef]
- Cani, P.D.; Everard, A.; Duparc, T. Gut microbiota, enteroendocrine functions and metabolism. Curr. Opin. Pharmacol. 2013, 13, 935–940. [Google Scholar] [CrossRef] [PubMed]
- Simrén, M.; Barbara, G.; Flint, H.J.; Spiegel, B.M.R.; Spiller, R.C.; Vanner, S.; Verdu, E.F.; Whorwell, P.J.; Zoetendal, E.G. Intestinal microbiota in functional bowel disorders: A Rome foundation report. Gut 2013, 62, 159–176. [Google Scholar] [CrossRef]
- Mayer, E.A.; Savidge, T.; Shulman, R.J. Brain–gut microbiome interactions and functional bowel disorders. Gastroenterology 2014, 146, 1500–1512. [Google Scholar] [CrossRef] [PubMed]
- Atkins, M.; Murray, H.B. DGBI overlap: A model for a transdiagnostic approach? Lancet Gastroenterol. Hepatol. 2023, 8, 596–597. [Google Scholar] [CrossRef]
- Okawa, Y.; Fukudo, S.; Sanada, H. Specific foods can reduce symptoms of irritable bowel syndrome and functional constipation: A review. Biopsychosoc. Med. 2019, 13, 2–6. [Google Scholar] [CrossRef]
- Duncanson, K.R.; Talley, N.J.; Walker, M.M.; Burrows, T.L. Food and functional dyspepsia: A systematic review. J. Hum. Nutr. Diet 2018, 31, 390–407. [Google Scholar] [CrossRef] [PubMed]
- Hreinsson, J.P.; Törnblom, H.; Tack, J.; Drossman, D.A.; Whitehead, W.E.; Bangdiwala, S.I.; Sperber, A.D.; Palsson, O.S.; Simrén, M. Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups. Gastroenterology 2023, 164, 1211–1222. [Google Scholar] [CrossRef]
- Wadolowska, L.; Stasiewicz, B. Procedura Opracowania Danych Żywieniowych z Kwestionariusza QEB; Uniwersytet Warmińsko-Mazurski w Olsztynie: Olsztyn, Poland, 2014. [Google Scholar]
- WHO. Physical Activity. 2020. Available online: https://www.who.int/news-room/fact-sheets/detail/physical-activity (accessed on 27 August 2023).
- Le Pluart, D.; Sabaté, J.M.; Bouchoucha, M.; Hercberg, S.; Benamouzig, R.; Julia, C. Functional gastrointestinal disorders in 35,447 adults and their association with body mass index. Aliment. Pharmacol. Ther. 2015, 41, 758–767. [Google Scholar] [CrossRef]
- Miwa, H. Life style in persons with functional gastrointestinal disorders large scale internet survey of lifestyle in Japan. Neurogastroenterol. Motil. 2012, 24, 464–471. [Google Scholar] [CrossRef]
- Jarocka-Cyrta, E.; Przybyłowicz, K.E. Rola FODMAP w zaburzeniach czynnościowych przewodu pokarmowego Część 2. Dieta z ograniczeniem FODMAP. Założenia, efekty kliniczne, niepożądane następstwa. Stand. Med. Pediatr. 2015, 12, 89–94. [Google Scholar]
- Zielińska, A. Ocena zależności między sposobem odżywiania a dolegliwościami u osób z zaburzeniami czynnościowymi przewodu pokarmowego. Piel. Zdr. Publ. 2014, 4, 227–237. [Google Scholar]
- Almario, C.V.; Ballal, M.L.; Chey, W.D.; Nordstrom, C.; Khanna, D.; Spiegel, B.M.R. Burden of Gastrointestinal Symptoms in the United States: Results of a Nationally Representative Survey of Over 71,000 Americans. Am. J. Gastroenterol. 2018, 113, 1701–1710. [Google Scholar] [CrossRef]
- Bardisi, B.; Halawani, A.H.; Halawani, H.H.; Alharbi, A.; Turkostany, N.; Alrehaili, T.; Radin, A.; Alkhuzea, N. Efficiency of diet change in irritable bowel syndrome. J. Family Med. Prim. Care 2018, 7, 946–951. [Google Scholar] [CrossRef] [PubMed]
- Balwierz, R.J.; Jasiński, K.; Osowski, M.; Grela, K.; Karpęcka-Gałka, E.; Kusakiewicz-Dawid, A.; Kotnicka-Graca, U. Rola diety i metod leczenia żywieniowego w ograniczeniu dolegliwości zespołu jelita drażliweg. Farm Pol. 2021, 77, 329–336. [Google Scholar] [CrossRef] [PubMed]
- Göktaş, Z.; Köklü, S.; Dikmen, D.; Öztürk, Ö.; Yılmaz, B.; Asıl, M.; Korkmaz, H.; Tuna, Y.; Kekilli, M.; Aksoy, E.K.; et al. Nutritional habits in functional dyspepsia and its subgroups: A comparative study. Scand. J. Gastroenterol. 2016, 51, 903–907. [Google Scholar] [CrossRef] [PubMed]
- Hayes, P.; Corish, C.; O’Mahony, E.; Quigley, E.M. A dietary survey of patients with irritable bowel syndrome. J. Hum. Nutr. Diet 2014, 27, 36–47. [Google Scholar] [CrossRef] [PubMed]
- Lee, H.J.; Kim, H.J.; Kang, E.H.; Jung, K.W.; Myung, S.-J.; Min, Y.W.; Choi, C.H.; Ryu, H.S.; Choi, J.K.; Kwon, J.G.; et al. Self-reported Food Intolerance in Korean Patients With Irritable Bowel Syndrome. J. Neurogastroenterol. Motil. 2019, 25, 222–232. [Google Scholar] [CrossRef] [PubMed]
- Böhn, L.; Störsrud, S.; Törnblom, H.; Bengtsson, U.; Simrén, M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more 74 severe symptoms and reduced quality of life. Am. J. Gastroenterol. 2013, 108, 634–641. [Google Scholar] [CrossRef]
- Guo, Y.B.; Zhuang, K.M.; Kuang, L.; Zhan, Q.; Wang, X.F.; Liu, S.D. Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver 2015, 9, 649–656. [Google Scholar] [CrossRef]
- Chirila, I.; Morariu, I.D.; Barboi, O.B.; Drug, V.L. The role of diet in the overlap between gastroesophageal reflux disease and functional dyspepsia. Turk. J. Gastroenterol. 2016, 27, 73–80. [Google Scholar] [CrossRef] [PubMed]
- Ligaarden, S.C.; Lydersen, S.; Farup, P.G. Diet in subjects with irritable bowel syndrome: A cross-sectional study in the general population. BMC Gastroenterol. 2012, 12, 61. [Google Scholar] [CrossRef] [PubMed]
- Huang, Z.P.; Wang, K.; Duan, Y.H.; Yang, G. Correlation between lifestyle and social factors in functional dyspepsia among college freshmen. J. Int. Med. Res. 2020, 48, 0300060520939702. [Google Scholar] [CrossRef] [PubMed]
- Nilholm, C.; Larsson, E.; Roth, B.; Gustafsson, R.; Ohlsson, B. Irregular Dietary Habits with a High Intake of Cereals and Sweets Are Associated with More Severe Gastrointestinal Symptoms in IBS Patients. Nutrients 2019, 11, 1279. [Google Scholar] [CrossRef] [PubMed]
Type of Product | Frequency of Consumption | |||||
---|---|---|---|---|---|---|
Several Times a Day % (n) | Once a Day % (n) | 3 or More Times a Week % (n) | Several Times a Month % (n) | I Do Not Consume % (n) | p-Value | |
Vegetables | 37.2% (87) | 23.1% (54) | 26.9% (63) | 12.4% (29) | 0.4% (1) | 0.034 * |
Fruits | 39.3% (92) | 34.6% (81) | 15.0% (35) | 10.3% (24) | 0.9% (2) | 0.003 * |
Meat | 10.7% (25) | 18.8% (44) | 26.9% (63) | 28.6% (67) | 15.0% (35) | 0.582 |
Fish | 0% (0) | 0% (0) | 12.8% (30) | 71.8% (168) | 15.4% (36) | 0.443 |
Wheat bread | 18.8% (44) | 23.9% (56) | 22.2% (52) | 16.7% (39) | 18.4% (43) | 0.873 |
Whole-grain bread | 17.5% (41) | 17.5% (41) | 16.2% (38) | 14.5% (34) | 34.2% (80) | 0.043 * |
Coarse-grain groats | 0.4% (1) | 2.6% (6) | 19.2% (45) | 47.0% (110) | 30.8% (72) | 0.032 * |
Wheat pasta | 1.2% (3) | 4.4% (10) | 35.0% (82) | 50.4% (118) | 9.0% (21) | 0.261 |
Whole wheat pasta | 0.4% (1) | 4.4% (10) | 15.8% (37) | 27.8% (65) | 51.6% (121) | 0.021 * |
Legumes | 0% (0) | 5.1% (12) | 9.8% (23) | 61.1% (143) | 23.9% (56) | 0.041 * |
Nonfermented dairy products | 20.6% (48) | 26.3% (62) | 21.1% (49) | 4.8% (11) | 27.2% (64) | 0.231 |
Fermented dairy products | 2.2% (5) | 14.9% (35) | 32.6% (76) | 32.0% (75) | 18.3% (43) | 0.128 |
Cottage cheese | 1.3% (3) | 3.8% (9) | 35.4% (83) | 20.9% (49) | 38.6% (90) | 0.123 |
Rennet cheeses | 3.0% (7) | 14.2% (33) | 46.2% (108) | 22.5% (53) | 14.2% (33) | 0.078 |
Coffee | 44% (103) | 20.1% (47) | 5.6% (13) | 18.4% (43) | 12% (28) | 0.323 |
Tea | 38.0% (89) | 19.2% (45) | 13.7% (32) | 22.2% (52) | 6.8% (16) | 0.289 |
Fast food | 0.4% (1) | 0% (0) | 7.3% (17) | 83.3% (195) | 9.0% (21) | 0.021 * |
Sweets | 7.3% (17) | 0% (0) | 35.0% (82) | 51.7% (121) | 6.0% (14) | 0.041 * |
Alcohol | 0% (0%) | 0% (0%) | 3.8% (9) | 81.2% (190) | 15.0% (35) | 0.037 * |
Category | Nausea | Constipation | Bloating | Belching | Diarrhea | Excessive Passing of Gas | Overflow | Fasting Abdominal Pain | Nighttime Abdominal Pain | Chronic Fatigue and Weakness | |
---|---|---|---|---|---|---|---|---|---|---|---|
Gender X ± SD | Woman n = 164 | 2.55 ± 0.65 | 1.68 ± 0.76 | 1.74 ± 0.76 | 2.18 ± 0.79 | 2.29 ± 0.79 | 2.31 ± 0.74 | 2.40 ± 0.75 | 2.55 ± 0.77 | 2.63 ± 0.64 | 2.30 ± 0.80 |
Man n = 70 | 2.67 ± 0.61 | 1.90 ± 0.87 | 1.77 ± 0.85 | 2.14 ± 0.91 | 2.15 ± 0.88 | 2.10 ± 0.87 | 2.14 ± 0.84 | 2.46 ± 0.86 | 2.63 ± 0.71 | 2.57 ± 0.77 | |
Total n = 234 | 2.59 ± 0.64 | 1.75 ± 0.80 | 1.75 ± 0.79 | 2.17 ± 0.82 | 2.25 ± 0.82 | 2.25 ± 0.79 | 2.32 ± 0.78 | 2.52 ± 0.80 | 2.63 ± 0.66 | 2.38 ± 0.80 | |
p-value | 0.179 | 0.056 | 0.765 | 0.774 | 0.268 | 0.053 | 0.020 * | 0.422 | 0.996 | 0.017 * | |
Age X ± SD | <30 years n = 76 | 2.55 ± 0.64 | 1.83 ± 0.77 | 1.91 ± 0.77 | 2.25 ± 0.77 | 2.37 ± 0.73 | 2.36 ± 0.73 | 2.41 ± 0.75 | 2.58 ± 0.75 | 2.67 ± 0.57 | 2.14 ± 0.78 |
31–40 years n = 74 | 2.51 ± 0.67 | 1.78 ± 0.78 | 1.89 ± 0.77 | 2.16 ± 0.83 | 2.09 ± 0.83 | 2.11 ± 0.79 | 2.23 ± 0.79 | 2.24 ± 0.90 | 2.49 ± 0.73 | 2.31 ± 0.87 | |
41–50 years n = 65 | 2.69 ± 0.58 | 1.60 ± 0.83 | 1.43 ± 0.75 | 2.15 ± 0.89 | 2.22 ± 0.89 | 2.32 ± 0.83 | 2.35 ± 0.84 | 2.72 ± 0.65 | 2.72 ± 0.65 | 2.83 ± 0.49 | |
>51 years n = 19 | 2.63 ± 0.69 | 1.79 ± 0.86 | 1.63 ± 0.76 | 1.89 ± 0.81 | 2.47 ± 0.77 | 2.16 ± 0.76 | 2.26 ± 0.73 | 2.68 ± 0.75 | 2.68 ± 0.67 | 2.05 ± 0.85 | |
Total n = 234 | 2.59 ± 0.64 | 1.75 ± 0.80 | 1.75 ± 0.79 | 2.17 ± 0.82 | 2.25 ± 0.82 | 2.25 ± 0.79 | 2.32 ± 0.78 | 2.52 ± 0.80 | 2.63 ± 0.66 | 2.38 ± 0.80 | |
p-value | 0.383 | 0.360 | 0.001 * | 0.416 | 0.121 | 0.205 | 0.545 | 0.002 * | 0.154 | 0.00 * | |
BMI X ± SD | Underweight n = 6 | 2.50 ± 0.55 | 1.50 ± 0.55 | 1.67 ± 0.82 | 1.83 ± 0.75 | 2.00 ± 0.89 | 1.67 ± 0.52 | 2.33 ± 0.82 | 2.00 ± 1.10 | 2.00 ± 0.89 | 1.67 ± 0.52 |
Norm n = 177 | 2.55 ± 0.67 | 1.72 ± 0.79 | 1.79 ± 0.80 | 2.19 ± 0.82 | 2.32 ± 0.79 | 2.28 ± 0.78 | 2.30 ± 0.79 | 2.53 ± 0.79 | 2.62 ± 0.67 | 2.37 ± 0.80 | |
Overweight n = 45 | 2.80 ± 0.46 | 1.96 ± 0.85 | 1.56 ± 0.72 | 2.11 ± 0.86 | 1.98 ± 0.89 | 2.20 ± 0.87 | 2.40 ± 0.78 | 2.60 ± 0.78 | 2.80 ± 0.55 | 2.62 ± 0.72 | |
Obesity n = 6 | 2.17 ± 0.75 | 1.33 ± 0.52 | 2.17 ± 0.41 | 2.17 ± 0.75 | 2.33 ± 0.82 | 2.33 ± 0.52 | 2.50 ± 0.84 | 2.33 ± 0.82 | 2.33 ± 0.52 | 1.50 ± 0.84 | |
Total n = 234 | 2.59 ± 0.64 | 1.75 ± 0.80 | 1.75 ± 0.79 | 2.17 ± 0.82 | 2.25 ± 0.82 | 2.25 ± 0.79 | 2.32 ± 0.78 | 2.52 ± 0.80 | 2.63 ± 0.66 | 2.38 ± 0.80 | |
p-value | 0.037 * | 0.138 | 0.183 | 0.719 | 0.071 | 0.279 | 0.828 | 0.344 | 0.019 * | 0.001 * |
Category | Milk and Dairy Products | Raw Vegetables and Fruits | Legumes | Coffee | Alcohol | Products High in Fiber | Products High in Fat | Fried Products | Spicy Products | |
---|---|---|---|---|---|---|---|---|---|---|
Gender X ± SD | Woman n = 164 | 1.88 ± 0.83 | 2.36 ± 0.80 | 2.32 ± 0.80 | 2.16 ± 0.81 | 2.27 ± 0.84 | 2.42 ± 0.81 | 2.37 ± 0.78 | 1.91 ± 0.86 | 1.80 ± 0.86 |
Man n = 70 | 1.84 ± 0.71 | 2.47 ± 0.74 | 2.44 ± 0.77 | 2.39 ± 0.79 | 2.33 ± 0.79 | 2.73 ± 0.59 | 2.16 ± 0.77 | 1.93 ± 0.79 | 1.76 ± 0.71 | |
Total n = 234 | 1.87 ± 0.79 | 2.40 ± 0.79 | 2.35 ± 0.80 | 2.23 ± 0.81 | 2.29 ± 0.82 | 2.51 ± 0.76 | 2.30 ± 0.78 | 1.91 ± 0.84 | 1.79 ± 0.82 | |
p-value | 0.757 | 0.345 | 0.269 | 0.049 * | 0.646 | 0.004 * | 0.060 | 0.868 | 0.722 | |
Age X ± SD | <30 years n = 76 | 1.95 ± 0.81 | 2.71 ± 0.63 | 2.55 ± 0.72 | 2.46 ± 0.76 | 2.42 ± 0.80 | 2.55 ± 0.76 | 2.39 ± 0.75 | 2.08 ± 0.84 | 2.07 ± 0.87 |
31–40 years n = 74 | 1.85 ± 0.82 | 2.27 ± 0.83 | 2.19 ± 0.87 | 2.18 ± 0.83 | 2.16 ± 0.84 | 2.35 ± 0.83 | 2.20 ± 0.79 | 1.89 ± 0.85 | 1.70 ± 0.75 | |
41–50 years n = 65 | 1.82 ± 0.75 | 2.18 ± 0.81 | 2.31 ± 0.77 | 2.03 ± 0.79 | 2.26 ± 0.82 | 2.65 ± 0.65 | 2.31 ± 0.79 | 1.72 ± 0.80 | 1.57 ± 0.75 | |
>51 years n = 19 | 1.79 ± 0.79 | 2.37 ± 0.68 | 2.37 ± 0.76 | 2.16 ± 0.83 | 2.37 ± 0.83 | 2.53 ± 0.77 | 2.32 ± 0.82 | 2.00 ± 0.82 | 1.74 ± 0.81 | |
Total n = 234 | 1.87 ± 0.79 | 2.40 ± 0.78 | 2.35 ± 0.80 | 2.23 ± 0.81 | 2.29 ± 0.82 | 2.51 ± 0.76 | 2.30 ± 0.78 | 1.91 ± 0.84 | 1.79 ± 0.82 | |
p-value | 0.740 | 0.000 * | 0.042 * | 0.014 * | 0.268 | 0.135 | 0.518 | 0.087 | 0.002 * | |
BMI X ± SD | Underweight n = 6 | 1.83 ± 0.98 | 2.67 ± 0.52 | 2.33 ± 1.03 | 2.00 ± 0.89 | 2.00 ± 1.10 | 2.00 ± 1.10 | 2.17 ± 0.98 | 2.00 ± 1.09 | 1.83 ± 0.98 |
Norm n = 177 | 1.81 ± 0.77 | 2.44 ± 0.78 | 2.41 ± 0.76 | 2.25 ± 0.79 | 2.32 ± 0.79 | 2.49 ± 0.77 | 2.29 ± 0.76 | 1.94 ± 0.83 | 1.84 ± 0.83 | |
Overweight n = 45 | 2.11 ± 0.83 | 2.18 ± 0.81 | 2.18 ± 0.89 | 2.18 ± 0.86 | 2.18 ± 0.91 | 2.73 ± 0.58 | 2.36 ± 0.80 | 1.80 ± 0.81 | 1.58 ± 0.72 | |
Obesity n = 6 | 1.83 ± 0.75 | 2.50 ± 0.84 | 2.00 ± 0.89 | 2.00 ± 1.10 | 2.50 ± 0.84 | 2.17 ± 0.98 | 2.33 ± 1.03 | 2.00 ± 1.10 | 1.83 ± 0.98 | |
Total n = 234 | 1.87 ± 0.79 | 2.40 ± 0.78 | 2.35 ± 0.80 | 2.23 ± 0.81 | 2.29 ± 0.82 | 2.51 ± 0.76 | 2.30 ± 0.78 | 1.91 ± 0.84 | 1.79 ± 0.82 | |
p-value | 0.154 | 0.178 | 0.226 | 0.730 | 0.528 | 0.045 * | 0.936 | 0.780 | 0.305 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Faruga-Lewicka, W.; Bielaszka, A.; Staśkiewicz-Bartecka, W.; Opiołka, S.; Kiciak, A.; Kardas, M. Evaluation of Diet and Symptom Severity in Disorder of Gut–Brain Interaction. J. Clin. Med. 2024, 13, 4132. https://doi.org/10.3390/jcm13144132
Faruga-Lewicka W, Bielaszka A, Staśkiewicz-Bartecka W, Opiołka S, Kiciak A, Kardas M. Evaluation of Diet and Symptom Severity in Disorder of Gut–Brain Interaction. Journal of Clinical Medicine. 2024; 13(14):4132. https://doi.org/10.3390/jcm13144132
Chicago/Turabian StyleFaruga-Lewicka, Wioleta, Agnieszka Bielaszka, Wiktoria Staśkiewicz-Bartecka, Sabina Opiołka, Agata Kiciak, and Marek Kardas. 2024. "Evaluation of Diet and Symptom Severity in Disorder of Gut–Brain Interaction" Journal of Clinical Medicine 13, no. 14: 4132. https://doi.org/10.3390/jcm13144132
APA StyleFaruga-Lewicka, W., Bielaszka, A., Staśkiewicz-Bartecka, W., Opiołka, S., Kiciak, A., & Kardas, M. (2024). Evaluation of Diet and Symptom Severity in Disorder of Gut–Brain Interaction. Journal of Clinical Medicine, 13(14), 4132. https://doi.org/10.3390/jcm13144132